T2 Biosystems, Inc. announced the successful amendment and extension to its Term Loan Agreement with CRG Servicing LLC. The amendment extends both the interest-only period and the maturity date by one year from December 31, 2024 to December 31, 2025, and permanently reduces the minimum cash covenant from $5,000,000 to $500,000. No other material amendments were made to the Term Loan Agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | +3.65% | -4.05% | -54.74% |
Apr. 23 | Top Premarket Decliners | MT |
Apr. 01 | T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-54.74% | 24.97M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- TTOO Stock
- News T2 Biosystems, Inc.
- T2 Biosystems, Inc. Announces Amendment and Extension of CRG Term Loan Agreement